FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

11236311000001104: Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40404101000001114 Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
40404201000001119 Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Is a Darunavir 300mg tablets 120 tablet true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Is pack of Prezista 300mg tablets (Janssen-Cilag Ltd) false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has active ingredient Darunavir ethanolate false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has active ingredient Darunavir ethanolate false Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has AMP Prezista 300mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has specific active ingredient Darunavir ethanolate true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Prezista 300mg tablets (Janssen-Cilag Ltd) 120 tablet Has basis of strength substance Darunavir true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start